Integrated Environmental Technologies 10-K 27 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 25, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.
Entity Central Index Key	1084031
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Period End Date	31-Dec-14
Document Type	10-K
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Filer Category	Smaller Reporting Company
Entity Well-Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$9,447,000
Entity Common Stock, Shares Outstanding		298,309,835

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash	$371,292	$1,049,399
Accounts receivable	37,098	28,250
Prepaid expenses	11,780	26,166
Inventory	117,690	126,952
Other receivable	111,200
Total current assets	649,060	1,230,767
Property and equipment, net	259,468	344,884
Total assets	908,528	1,575,651
Current liabilities:
Accounts payable	154,167	41,320
Accrued expenses	403,520	47,954
Customer deposits	2,000	38,109
Convertible debentures	501,125	25,000
Note payable	46,546	75,513
Total current liabilities	1,107,358	227,896
Convertible debentures		476,125
Note payable		46,546
Total liabilities	1,107,358	750,567
Commitments and contingencies
Stockholders' equity (deficiency):
Common stock, $.001 par value; 400,000,000 shares authorized; 253,178,774 and 229,971,926 shares issued and outstanding, respectively	253,179	229,972
Additional paid-in capital	21,262,811	20,075,764
Accumulated deficit	-21,714,820	-19,480,652
Total stockholders' equity (deficiency)	-198,830	825,084
Total liabilities and stockholders' equity (deficiency)	$908,528	$1,575,651

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	253,178,774	229,971,926
Common stock, shares outstanding	253,178,774	229,971,926

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Sales	$151,397	$93,866
Leasing and Licensing Fees	34,180	52,500
Total revenues	185,577	146,366
Cost of sales	58,405	28,930
Gross profit	127,172	117,436
Operating expenses:
General and administrative expense	1,297,673	1,243,196
Sales and marketing expense	785,155	447,832
Research and development expense	266,298	211,822
Total operating expenses	2,349,126	1,902,850
Loss from operations	-2,221,954	-1,785,414
Other income (expense):
Interest and other income	36,109	74
Interest expense	-48,323	-45,913
Total other income (expense)	-12,214	-45,839
Net loss	($2,234,168)	($1,831,253)
Net loss per share, basic and diluted	($0.01)	($0.01)
Weighted average shares outstanding, basic and diluted	238,279,810	187,333,118

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Stockholders' Deficit
Beginning Balance at Dec. 31, 2012		$150,369	$17,151,303	($17,649,399)
Beginning Balance, shares at Dec. 31, 2012		150,368,500
Common stock issued for cash, net of offering costs	2,763,605	74,388	2,689,217
Common stock issued for cash, net of offering costs, shares		74,388,766
Common stock issued as payment on principal and interest on convertible debentures	38,090	401	37,689
Common stock issued as payment on principal and interest on convertible debentures, shares		400,947
Common stock issued as payment of accounts payable	70,250	1,714	68,536
Common stock issued as payment of accounts payable, shares		1,713,839
Common stock issued as settlement of litigation	26,550	450	26,100
Common stock issued as settlement of litigation, shares		450,000
Stock-based compensation	105,569	2,650	102,919
Stock-based compensation, shares		2,649,874
Net loss	-1,831,253			-1,831,253
Balance at Dec. 31, 2013	825,084	229,972	20,075,764	-19,480,652
Balance, shares at Dec. 31, 2013		229,971,926
Common stock issued for cash, net of offering costs	1,045,996	20,974	1,025,022
Common stock issued for cash, net of offering costs, shares		20,973,693
Common stock issued as payment on principal and interest on convertible debentures	38,090	438	37,652
Common stock issued as payment on principal and interest on convertible debentures, shares		437,816
Common stock issued as payment of accounts payable	53,125	787	52,338
Common stock issued as payment of accounts payable, shares		786,628
Stock-based compensation	81,593	1,008	80,585
Stock-based compensation, shares		1,008,711
Stock based compensation accrued for payment	-8,550		-8,550
Net loss	-2,234,168			-2,234,168
Balance at Dec. 31, 2014	($198,830)	$253,179	$21,262,811	($21,714,820)
Balance, shares at Dec. 31, 2014		253,178,774

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($2,234,168)	($1,831,253)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	85,416	172,234
Stock-based compensation expense	81,593	105,569
Stock issued as settlement of litigation		26,550
Write-off of accounts receivable	920	2,341
Gain on settlement of customer deposit	-36,109
Changes in operating assets and liabilities:
Accounts receivable	-21,367	-11,879
Prepaid expenses	14,386	-10,233
Note receivable		3,590
Inventory	9,262	-60,015
Accounts payable	153,715	-123,232
Accrued expenses	297,762	-73,919
Customer deposits		2,000
Net cash used in operating activities	-1,648,590	-1,798,247
Cash flows from investing activity:
Purchase of equipment		-66,507
Cash flows from financing activities:
Proceeds from sale of common stock, net of offering costs	1,045,996	2,763,605
Repayment of note payable	-75,513	-29,941
Net cash provided by financing activities	970,483	2,733,664
(Decrease) increase in cash	-678,107	868,910
Cash - beginning of year	1,049,399
Cash - end of year	371,292	1,049,399
Supplemental disclosure of cash flow information:
Cash paid for interest	7,232	5,032
Cash paid for income taxes	700
Noncash operating activities:
Issuance of 492,614 and 1,713,839 shares of common stock, respectively, as payment of director fees	32,250	70,250
Issuance of 437,816 and 400,947 shares of common stock, respectively, as payment of interest on convertible debenture	38,090	38,090
Issuance of 450,000 shares of common stock as settlement of litigation		26,550
Issuance of 294,014 shares of common stock as payment of accounts payable	20,875
Noncash investing activity:
Issuance of note payable as payment for equipment		152,000
Noncash financing activities:
Issuance of 758,711 and 1,649,874 shares of common stock, respectively, as payment of offering costs related to private placements	44,252	109,100
Issuance of warrant to purchase 401,567 shares of common stock as payment of offering costs related to private placements		$23,188

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Parenthetical)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Statement Of Cash Flows [Abstract]
Common stock issued as payment of director fees	492,614	1,713,839
Common stock issued as payment of interest on convertible debenture	437,816	400,947
Common stock shares issued as settlement of litigation	450,000	450,000
Common stock issued as payment of accounts payable, shares	294,014	294,014
Common stock issued as payment offering costs related to private placements	758,711	1,649,874
Common stock warrants issued as payment offering costs related to private placements	401,567	401,567

Organization_and_Description_o

Organization and Description of Business	12 Months Ended
	Dec. 31, 2014
Organization and Description Of Business and Basis Of Presentation [Abstract]
Organization and Description of Business	1	Organization and Description of Business
	Integrated Environmental Technologies, Ltd. (the “Company”) was originally incorporated in Delaware on February 2, 1999 and is currently a Nevada corporation. The Company is headquartered in Little River, South Carolina and operates its business through its wholly-owned subsidiary, I.E.T., Inc., a Nevada corporation incorporated on January 11, 2002.
	The Company markets its products and equipment under the umbrella brand name, EcoTreatments™. The Company produces a hypochlorous acid solution (“Anolyte”) as well as an anti-oxidizing, mildly alkaline solution (“Catholyte”), that provide an environmentally friendly and effective alternative for cleaning, sanitizing and disinfecting as compared to the hazardous chemicals traditionally prevalent in commercial use. The Company markets and sells Anolyte under the brand name, Excelyte® and markets Catholyte under the brand name, Catholyte Zero™, although the majority of sales and marketing efforts are focused on Excelyte®. The Company manufactures proprietary equipment, which it markets under the brand name EcaFlo™, to produce Anolyte and Catholyte for distribution by the Company and, under certain circumstances, such equipment is leased by the Company to customers for use at their facilities.

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2014
Organization and Description Of Business and Basis Of Presentation [Abstract]
Basis of Presentation	2	Basis of Presentation
	The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant recurring operating losses and negative cash flows from operations. The Company had a working capital deficiency of $458,298 and an accumulated deficit of $21,714,820 as of December 31, 2014. The Company also has no lending relationships with commercial banks and is dependent on the completion of financings involving the private placement of its securities in order to continue operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	The Company does not anticipate establishing any lending relationships with commercial banks in the foreseeable future due to its limited operations and assets. The Company continues to execute its strategy of selling Anolyte and Catholyte solutions and leasing its EcaFlo™ equipment to fund its operations and is focused on obtaining additional capital through the private placement of its securities. The Company is pursuing potential equity and/or debt investors and, from time to time, has engaged placement agents to assist it in this initiative. While the Company is pursuing the opportunities and actions described above, there can be no assurance that it will be successful in its efforts. If the Company is unable to secure additional capital, it will explore other strategic alternatives, including, but not limited to, the sale of the Company. Any additional equity financing may result in substantial dilution to the Company’s stockholders.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Summary Of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	3	Summary of Significant Accounting Policies
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company based its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate. All of these estimates reflect management's best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions persist longer or deteriorate further than expected, it is reasonably possible that the judgments and estimates could change.
	Concentration of Credit Risk
	The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts which, at times, exceed federally-insured limits.
	The Company principally sells its products directly to commercial customers in the oil and gas industry and in several other industries. The Company’s oil and gas customers are located in Utah and in New Mexico and the Company’s other customers are located in diversified geographical regions throughout the United States. During the year ended December 31, 2014, four customers accounted for 29%, 15%, 13% and 10%, respectively, of revenues. During the year ended December 31, 2013, four customers accounted for 22%, 14%, 14% and 11%, respectively, of revenues. No other customer accounted for more than 10% of our revenues during the year ended December 31, 2014 or 2013. The Company regularly evaluates the creditworthiness of its customers.
	Accounts Receivable
	Accounts receivable consist of trade receivables recorded at original invoice amount, less any allowance for uncollectible accounts. Trade credit is generally extended on a short-term basis; thus trade receivables do not bear interest. Trade receivables are periodically evaluated for collectability by considering a number of factors, including the length of time an invoice is past due, the customer’s creditworthiness and historical bad debt experience. Changes in the estimated collectability of trade receivables are recorded in the results of operations for the period in which the estimate is revised. Trade receivables that are deemed uncollectible are offset against the allowance for uncollectible accounts. The Company generally does not require collateral for trade receivables.
	Inventory
	Inventory is recorded at the lower of cost or market using the first-in, first-out method. The Company determines its reserve for obsolete inventory by considering a number of factors, including product shelf life, marketability, and obsolescence. The Company determines the need to write down inventories by analyzing product expiration, market conditions, and salability of its products.
	Property and Equipment
	Property and equipment are recorded at cost less allowances for depreciation. The straight-line method of depreciation is used for all property and equipment. Repair and maintenance costs are expensed as incurred. Equipment is depreciated over an estimated useful life ranging from three to seven years.  Leasehold improvements are depreciated over the shorter of the original term of lease or the estimated useful life of the improvement.
	Fair Value of Financial Instruments
	The carrying amounts of the Company’s financial instruments, which include cash, accounts receivable, other receivables, accounts payable and accrued expenses, approximate their fair values due to their short maturities.
	The fair value of notes payable, convertible debentures and convertible promissory notes approximate fair value since each of these investments are at market rates currently available to the Company.
	Long-Lived Assets
	The Company reviews its long-lived assets, which include property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with Accounting Standards Codification (“ASC”) 360-10-35-15, “Property, Plant and Equipment-Impairment or Disposal of Long-Lived Assets.” Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by the assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. There were no material impairment charges related to the Company’s property and equipment during the year ended December 31, 2014 or 2013.
	Revenue Recognition
	General
	Revenue is recognized when persuasive evidence of an arrangement exists, title and risk of ownership have passed, the sales price is fixed or determinable and collectability is probable. Generally, these criteria are met at the time the product is shipped. Provisions for estimated returns, rebates and discounts are provided for at the time the related revenue is recognized. Freight revenue billed to customers is included in sales and the related shipping expense is included in cost of sales. Service revenue is recognized in the period the service is performed or ratably over the period of the related service contract.
	Leases
	When the Company leases its equipment, the accounting involves specific determinations, which often involve complex provisions and significant judgments. The four criteria of the accounting standard that the Company uses in the determination of a sales-type lease or operating-type lease are: (a) a review of the lease term to determine if it is equal to or greater than 75% of the economic life of the equipment; (b) a review of the minimum lease payments to determine if they are equal to or greater than 90% of the fair market value of the equipment; (c) a determination of whether or not the lease transfers ownership to the lessee at the end of the lease term; and (d) a determination of whether or not the lease contains a bargain purchase option. If the lease transaction meets one of the four criteria, then it is recorded as a sales-type lease; otherwise, it is recorded as an operating-type lease. Additionally, the Company assesses whether collectability of the lease payments is reasonably assured and whether there are any significant uncertainties related to costs that it has yet to incur with respect to the lease.
	When a customer enters into a sales-type lease agreement, the sales and cost of sales are recognized at the inception of the lease. The sales-type lease consists of the sum of the total minimum lease payments less unearned interest income and estimated executory cost. Minimum lease payments are part of the lease agreement between the Company (lessor) and the customer (lessee).  The discount rate implicit in the sales-type lease is used to calculate the present value of minimum lease payments, which the Company records as a lease receivable.  The minimum lease payment consists of the gross lease payments net of executory costs and contingencies, if any. Unearned interest income is amortized over the lease term to produce a constant periodic rate of return on net investment in the lease.  While revenue is recognized at the inception of the lease, the cash flow from the sales-type lease occurs over the course of the lease, which results in interest income. Sales-type lease revenue consists of the initial sale of the equipment shipped and the interest and license elements of the lease payments as they are earned.
	When a customer enters into an operating-type lease agreement, equipment lease revenue is recognized on a straight-line basis over the life of the lease, while the cost of the leased equipment is depreciated over its estimated useful life.
	Income Taxes
	The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires that the Company recognize a current tax liability or asset for current taxes payable or refundable and a deferred tax liability or asset for the estimated future tax effects of temporary differences and carry-forwards to the extent they are realizable. The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be realized. While the Company has considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, in the event the Company was to determine that it would be able to realize the deferred tax assets in the future in excess of the net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made. Likewise, deferred tax assets are reduced by a valuation allowance, when in the Company’s opinion, it is more likely than not that some portion or all of the deferred tax asset will not be realized.
	Research and Development
	The Company expenses research and development costs as incurred.
	Stock-Based Compensation
	The Company accounts for stock-based payments to employees in accordance with ASC 718, “Stock Compensation” (“ASC 718”). Stock-based payments to employees include issuances of stock, grants of stock options and issuance of warrants that are recognized in the consolidated statement of operations based on their fair values at the date of grant or issuance.
	The Company accounts for stock-based payments to non-employees in accordance with ASC 718 and Topic 505-50, “Equity-Based Payments to Non-Employees.” Stock-based payments to non-employees include issuances of stock, grants of stock options and issuances of warrants that are recognized in the consolidated statement of operations based on the value of the vested portion of the award over the requisite service period as measured at its then-current fair value as of each financial reporting date.
	The Company calculates the fair value of option grants and warrant issuances utilizing the Black-Scholes pricing model. The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. ASC 718 requires forfeitures to be estimated at the time stock options are granted and warrants are issued to employees and non-employees, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered stock option or warrant. The Company estimates forfeiture rates for all unvested awards when calculating the expense for the period. In estimating the forfeiture rate, the Company monitors both stock option and warrant exercises as well as employee termination patterns.
	The resulting stock-based compensation expense for both employee and non-employee awards is generally recognized on a straight-line basis over the requisite service period of the award.
	During the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense as follows:
			Year Ended
			December 31,
			2014		2013
	General and administrative		$	61,712	$	90,969
	Sales and marketing			15,498		10,220
	Research and development			4,383		4,380
	Total		$	81,593	$	105,569
	For the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense related to stock options granted to employees and directors of $37,724 and $48,607, respectively. For the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense related to common stock and warrants issued to non-employees of $43,869 and $56,962, respectively.
	Net Loss Per Common Share
	Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect, in periods in which they have a dilutive effect, the impact of common shares issuable upon exercise of stock options and warrants and conversion of convertible debt that are not deemed to be anti-dilutive. The dilutive effect of the outstanding stock options and warrants is computed using the treasury stock method.
	For the year ended December 31, 2014, diluted net loss per share did not include the effect of 4,846,920 shares of common stock issuable upon the exercise of outstanding stock options, 28,908,878 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debentures, as their effect would be anti-dilutive.
	For the year ended December 31, 2013, diluted net loss per share did not include the effect of 4,980,254 shares of common stock issuable upon the exercise of outstanding stock options, 36,844,565 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debentures, as their effect would be anti-dilutive.
	Reclassifications
	Certain reclassifications have been made to prior periods to conform to current presentations.
	Recent Accounting Pronouncements Applicable to the Company
	The Company does not believe there are any recently issued, but not yet effective, accounting standards that would have a significant impact on the Company’s financial position or results of operations.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2014
Inventory [Abstract]
Inventory	4	Inventory
	As of December 31, 2014 and December 31, 2013, inventory consisted of parts and materials totaling $117,690 and $126,952, respectively.
	During March 2013, the Company reclassified $17,487 of EcaFlo™ equipment from finished goods inventory to property and equipment. The Company no longer intends to sell its EcaFlo™ equipment but rather will either utilize the EcaFlo™ equipment to manufacture Anolyte and Catholyte solutions to be sold by the Company or lease the EcaFlo™ equipment to third parties.

Other_Receivable

Other Receivable	12 Months Ended
	Dec. 31, 2014
Other Receivable [Abstract]
Other Receivable	5	Other Receivable
	Effective January 1, 2013, the Company entered into a license agreement (the “License Agreement”) with a third party related to the use by the third party of the Company’s United States Environmental Protection Agency (the “EPA”) registration for its Anolyte solution (the “Registration”). Pursuant to the License Agreement, the licensee agreed to indemnify the Company for any costs or expenses incurred by the Company as it related to the licensee’s use of the Registration. During August 2014, the Company was notified by the EPA that the licensee was not in compliance with the Registration. As a result of the licensee’s actions, in February 2015, the Company, as the owner of the Registration, agreed to pay a penalty of $87,344 to the EPA. On March 5, 2015, the Company received $124,844 from the licensee as indemnification for the costs incurred by the Company related to this matter, which consisted of the $87,344 penalty plus $37,500 of legal expenses the Company incurred ($23,856 incurred during the year ended December 31, 2014).
	As of December 31, 2014, the Company recorded a receivable due from the licensee in the amount of $111,200, representing the amount reimbursed by the Licensor for the $87,344 penalty and the $23,856 of legal fees incurred by the Company as of December 31, 2014. In addition, as of December 31, 2014, the Company recorded an accrued liability of $87,344 to account for the $87,344 penalty (see Note 7).

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property and Equipment [Abstract]
Property and Equipment	6	Property and Equipment
	As of December 31, 2014 and 2013, property and equipment, on a net basis, consisted of the following (see Note 4):
			Year Ended
			December 31,
			2014			2013
	Leasehold improvements		$	328,977		$	328,977
	Equipment			437,504			437,504
				766,481			766,481
	Less:  Accumulated depreciation			(507,013	)		(421,597	)
			$	259,468		$	344,884

Accrued_Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2014
Accrued Expenses [Abstract]
Accrued Expenses	7	Accrued Expenses
	As of December 31, 2014 and December 31, 2013, accrued expenses consisted of the following:
			Year Ended
			December 31,
			2014		2013
	Accrued compensation		$	253,305	$	--
	Accrued penalty (see Note 5)			87,344		--
	Accrued interest (see Note 9)			27,321		24,321
	Accrued professional fees			22,000		22,000
	Accrued other expenses			13,550		1,633
			$	403,520	$	47,954

Customer_Deposits

Customer Deposits	12 Months Ended
	Dec. 31, 2014
Customer Deposits [Abstract]
Customer Deposits	8	Customer Deposits
	On March 29, 2011, the Company issued a credit to purchase equipment to a consultant in the amount of $36,109 as payment to the consultant for consulting services rendered to the Company. During the year ended December 31, 2014, the Company determined that this credit would not be utilized by the consultant. Accordingly, the Company recorded other income of $36,109 related to the gain on the settlement of this customer deposit. As of December 31, 2014 and 2013, the Company recorded $0 and $36,109, respectively, as a customer deposit.
	Pursuant to the terms of the License Agreement, the Company received a deposit of $2,000.

Convertible_Debentures

Convertible Debentures	12 Months Ended
	Dec. 31, 2014
Convertible Debentures [Abstract]
Convertible Debentures	9	Convertible Debentures
	April 2007 Convertible Debenture
	On April 26, 2007, in a private placement, the Company issued a convertible debenture to an individual accredited investor in the principal amount of $25,000. This convertible debenture matured on January 2, 2009 and remains unpaid. The convertible debenture accrues interest at a rate of 12% per annum and is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.40 per share. An aggregate of 62,500 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on this convertible debenture at the current conversion price of $0.40 per share.
	For the years ended December 31, 2014 and 2013, the Company recorded a total of $3,000 and $2,992, respectively, of interest expense related to this convertible debenture. As of December 31, 2014 and 2013, the outstanding principal on this convertible debenture was $25,000 and the accrued and unpaid interest was $13,441 and $10,441, respectively, which is included as a component of accrued expenses (see Note 7).
	Zanett Convertible Debentures
	On August 21, 2012, the Company issued to Zanett Opportunity Fund, Ltd. (“Zanett”) an 8% convertible debenture in the amount of $476,125 (the “Zanett August 2012 Debenture”). In connection with this private placement, the Company refinanced an 8% convertible debenture, in the principal amount of $376,125, issued to Zanett on July 7, 2011 (the “Zanett July 2011 Debenture”) and refinanced an 8% convertible secured promissory note, in the principal amount of $100,000, issued to Zanett on September 23, 2011 (the “Zanett September 2011 Note”). As a result of the issuance of the Zanett August 2012 Debenture, the Zanett July 2011 Debenture and the Zanett September 2011 Note were cancelled.
	The Zanett August 2012 Debenture has a three-year term maturing on August 21, 2015 and bears interest at a rate of 8% per annum. Interest is payable in annual installments in cash or, at the option of the Company, in shares of the Company’s common stock. If the Company elects to pay the interest in shares of its common stock, the number of shares issued as payment will be equal to the quotient of the unpaid interest divided by the market price of the Company’s common stock, as defined in the Zanett August 2012 Debenture.
	The entire principal amount of the Zanett August 2012 Debenture is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.10 per share. In addition, at the option of the Company, the entire principal amount of the Zanett August 2012 Debenture is convertible into shares of the Company’s common stock at $0.10 per share upon the occurrence of the merger or acquisition of the Company or if the average closing price of the Company’s common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share. The quoted market price of the Company’s common stock on August 21, 2012 was $0.05 per share. An aggregate of 4,761,250 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on the Zanett August 2012 Debenture at the current conversion price of $0.10 per share.
	On August 22, 2013, the Company issued 400,947 shares of the Company’s common stock to Zanett as payment of $38,090 of accrued interest due on the Zanett August 2012 Debenture for the period commencing August 21, 2012 through August 20, 2013. The number of shares of the Company’s common stock issued as payment of the accrued interest was calculated based on the market price of the Company’s common stock ($0.095 per share) as defined in the Zanett August 2012 Debenture.
	On October 10, 2014, the Company issued 437,816 shares of the Company’s common stock to Zanett as payment of $38,090 of accrued interest due on the Zanett August 2012 Debenture for the period commencing August 21, 2013 through August 20, 2014. The number of shares of the Company’s common stock issued as payment of the accrued interest was calculated based on the market price of the Company’s common stock ($0.087 per share) as defined in the Zanett August 2012 Debenture.
	For each of the years ended December 31, 2014 and 2013, the Company recorded $38,090 of interest expense related to the Zanett August 2012 Debenture. As of December 31, 2014, the outstanding principal on the Zanett August 2012 Debenture was $476,125, which was recorded as a component of current convertible debentures, and the accrued and unpaid interest was $13,880, which was included as a component of accrued expenses (see Note 7). As of December 31, 2013, the outstanding principal on the Zanett August 2012 Debenture was $476,125, which was recorded as a component of non-current convertible debentures, and the accrued and unpaid interest was $13,880, which was included as a component of accrued expenses (see Note 7).

Note_Payable

Note Payable	12 Months Ended
	Dec. 31, 2014
Note Payable [Abstract]
Note Payable	10	Note Payable
	On June 17, 2013, the Company and Benchmark Performance Group, Inc. (“Benchmark”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), whereby the Company purchased nineteen EcaFlo™ machines owned by Benchmark as well as the rights to the Excelyte® trademark and certain other intangible assets. The purchase price for the nineteen EcaFlo™ machines, the Excelyte® trademark and other intangible assets was $190,000.
	The Company paid $38,000 in conjunction with the closing of the Asset Purchase Agreement and issued a promissory note with a principal balance of $152,000 (the “Benchmark Note”). The Benchmark Note bears interest at a rate of 7% per annum and requires the Company to make twenty-four monthly payments of $6,805 commencing August 1, 2013. The Benchmark Note is secured by the nineteen EcaFlo™ machines.
	For the years ended December 31, 2014 and 2013, the Company recorded $6,152 and $4,086, respectively, of interest expense related to the Benchmark Note. As of December 31, 2014, the outstanding principal on the Benchmark Note was $46,546, which is recorded as a current note payable. As of December 31, 2013, the outstanding principal on the Benchmark Note was $122,059 (current portion: $75,513; long-term portion: $46,546).

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Income Taxes	11	Income Taxes
	The difference between the statutory federal income tax rate on the Company’s pre-tax loss and the Company’s effective income tax rate is summarized as follows:
			Years Ended
			December 31,						December 31,
			2014						2013
			Amount			Percent			Amount			Percent
	Income tax provision at federal statutory rate		$	(759,617	)		34	%	$	(622,626	)		34	%
	Effect of state taxes, net of federal benefit			(67,025	)		3			(54,938	)		3
	Change in valuation allowance			793,408			(36	)		679,700			(37	)
	Other			(33,234	)		(1	)		(2,136	)		--
			$	--			--	%	$	--			--	%
	Significant components of the Company’s deferred tax assets as of December 31, 2014 and 2013 are shown below. In determining whether the deferred tax assets will be realized, the Company considers numerous factors, including historical profitability, estimated future taxable income and the industry in which it operates. As of December 31, 2014 and 2013, a valuation allowance was recorded to fully offset the net deferred tax asset, as it was determined by management that the realization of the deferred tax asset was not likely to occur in the foreseeable future. The valuation allowance increased $793,408 during the year ended December 31, 2014, attributable primarily to Company’s continuing operating losses for the year ended December 31, 2014 and the Company’s belief that its remaining net operating losses would not be realized.
	The tax effects of temporary differences and net operating loss carry-forwards that give rise to deferred taxes consist of the following:
			Years Ended
			December 31,
			2014			2013
	Net operating loss		$	7,471,805		$	6,710,397
	Depreciation and amortization			65,820			53,604
	Stock based compensation			328,993			309,208
	Total gross deferred tax assets			7,866,618			7,073,209
	Valuation allowance			(7,866,618	)		(7,073,209	)
	Net deferred tax assets		$	--		$	--
	As of December 31, 2014, the Company had federal and state operating losses of approximately $19,989,000. Both the federal and state operating losses begin to expire in the years 2021 through 2034.
	Utilization of the net operating loss carry-forwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), and similar state provisions. The Company has not performed a detailed analysis to determine whether an ownership change under Section 382 of the Internal Revenue Code occurred. The effect of an ownership change would be the imposition of an annual limitation on the use of net operating loss carry-forwards attributable to periods before the change.
	The Company’s federal and state tax positions are evaluated based on whether it is more likely than not that a tax position will be sustained upon examination. The Company has identified no federal or state tax positions taken that it would consider to be a material uncertain tax position.
	The Company’s 2011, 2012 and 2013 federal and state income tax returns are open for examination by the applicable governmental authorities.

Stockholders_Equity_Deficiency

Stockholders' Equity (Deficiency)	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity (Deficiency) [Abstract]
Stockholders' Equity (Deficiency)	12	Stockholders’ Equity (Deficiency)
	Common Stock
	For the year ended December 31, 2013, the Company sold an aggregate of 74,388,766 shares of its common stock for an aggregate purchase price of $2,827,700 (weighted average per share price of $0.038). Included in these amounts were 8,333,334 shares of the Company’s common stock that were sold to E. Wayne Kinsey, III, a member of the Company’s board of directors, in a private placement for an aggregate purchase price of $250,000, or $0.03 per share, which was the same price that the Company sold shares of its common stock to other non-affiliated investors in the private placement. The Company paid an aggregate of $64,095 of offering costs in cash and issued 1,649,874 shares of common stock to non-affiliated third parties as payment of $109,100 of offering costs related to these sales of common stock.
	For the year ended December 31, 2013, the Company issued an aggregate of 1,000,000 shares of common stock to non-affiliated third parties as payment for investor relations services. The total expense associated with these issuances was $43,550, representing the fair value of the shares of common stock on the dates of issuance (weighted average per share price of $0.044).
	For the year ended December 31, 2013, the Company issued an aggregate of 1,713,839 shares of common stock as payment of $70,250 of accounts payable due certain members of the Company’s board of directors for board-related services rendered to the Company. The common stock was issued at per share prices equal to the Company’s quoted market price on the dates the issuances were either authorized by the Company’s board of directors (weighted average per share price of $0.041).
	For the year ended December 31, 2014, the Company sold an aggregate of 20,973,693 shares of its common stock for an aggregate purchase price of $1,093,690 (weighted average per share price of $0.052). The Company paid an aggregate of $47,694 of offering costs in cash and issued 758,711 shares of common stock to non-affiliated third parties as payment of $44,252 of offering costs related to these sales of common stock.
	For the year ended December 31, 2014, the Company issued 250,000 shares of common stock to a non-affiliated third party as payment for marketing services. The total expense associated with this issuance was $20,000, representing the fair value of the shares of common stock on the date of issuance (per share price of $0.08).
	For the year ended December 31, 2014, the Company issued an aggregate of 786,628 shares of common stock as payment of $32,250 of accounts payable due certain members of the Company’s board of directors for board-related services rendered to the Company and $20,875 of accounts payable due non-affiliated third parties for investor relations services. The common stock was issued at per share prices equal to the Company’s quoted market price on the dates the issuances were either authorized by the Company’s board of directors or occurred (weighted average per share price of $0.068).
	Stock Options
	The Company currently has two stock option/stock compensation plans in place: the 2010 Stock Incentive Plan and the 2012 Equity Incentive Plan (collectively, the “Equity Incentive Plans”).
	The 2010 Stock Incentive Plan was approved by the stockholders in September 2010. The Company had reserved for issuance an aggregate of 10,000,000 shares of common stock under the 2010 Stock Incentive Plan. As of December 31, 2014, stock options to purchase 3,846,920 shares of the Company’s common stock were outstanding under the 2010 Stock Incentive Plan and 90,500 shares of the Company’s common stock had been issued under the 2010 Stock Incentive Plan. As a result of the adoption of the Company’s 2012 Equity Incentive Plan, no further awards are permitted under the 2010 Stock Incentive Plan.
	The 2012 Equity Incentive Plan was approved by the stockholders in May 2012. The 2012 Equity Incentive Plan is designed to encourage and enable employees and directors of the Company to acquire or increase their holdings of common stock and other proprietary interests in the Company. The 2012 Equity Incentive Plan is intended to promote these individuals’ interests in the Company, thereby enhancing the efficiency, soundness, profitability, growth and stockholder value of the Company. The 2012 Equity Incentive Plan provides for grants and/or awards in the form of incentive and non-qualified stock option grants, stock appreciation rights, restricted stock awards, performance share awards, phantom stock awards and dividend equivalent awards.
	The original aggregate number of shares of common stock which could be awarded under the 2012 Equity Incentive Plan was 14,000,000 shares, subject to adjustment as provided in the 2012 Equity Incentive Plan. As of December 31, 2014, options to purchase 1,000,000 shares of the Company’s common stock were outstanding under the 2012 Equity Incentive Plan and up to 13,000,000 shares of the Company’s common stock remain available for awards under the 2012 Equity Incentive Plan. Effective February 25, 2015, as permitted under the 2012 Equity Incentive Plan, the Company’s board of directors increased the number of shares of common stock that could be awarded under the 2012 Equity Incentive Plan to 37,950,000 shares.
	Common stock grants and stock option awards under the Equity Incentive Plans were granted or issued at prices as determined by the Company’s compensation committee, but such prices were not less than the fair market value of the Company's common stock on the date of grant or issuance. Stock options granted and outstanding to date consist of both incentive stock options and non-qualified stock options.
	A summary of stock option transactions under the Equity Incentive Plans during the years ended December 31, 2014 and 2013 is set forth below:
			Stock				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
			Option Shares
	Outstanding at December 31, 2012			5,813,587			$	0.18			$	--
	Granted during the period			--				--
	Exercised during the period			--				--
	Terminated during the period			(833,333	)		$	0.2
	Outstanding at December 31, 2013			4,980,254			$	0.18			$	55,605
	Granted during the period			1,000,000				0.09
	Exercised during the period			--				--
	Terminated during the period			(1,133,334	)		$	0.24
	Outstanding at December 31, 2014			4,846,920			$	0.15			$	--
	Exercisable at December 31, 2014			3,846,920			$	0.16			$	--
	Exercisable at December 31, 2013			3,313,586			$	0.12			$	42,136
	The fair value of stock options granted during the year ended December 31, 2014 was $57,035 and was calculated using the Black-Scholes pricing model with the following weighted average assumptions:
	Exercise price		$	0.09
	Grant date stock price		$	0.09
	Expected volatility			139	%
	Risk-free interest rates			2.39	%
	Risk of forfeiture			35	%
	Expected life (in years)			10
	Dividend yield			0	%
	The risk-free interest rate is based on a treasury instrument, the term of which is consistent with the expected life of the stock options at the date of grant. In projecting expected stock price volatility, the Company used historical stock price volatility of its common stock which the Company believes is representative of future volatility. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.
	Information with respect to outstanding stock options and stock options exercisable as of December 31, 2014 that were granted to employees, directors and service providers is as follows:
					Stock Options Outstanding										Stock Options Exercisable
	Exercise				Number of Shares Available Under Outstanding Stock				Weighted Average Exercise Price Per Common Share				Weighted Average Remaining Contractual Life (Years)		Number of Shares Available for Purchase Under Outstanding Stock		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
	Price				Options										Options
	$	0.09				1,000,000			$	0.09				9.7		--	$	0.09		--
	$	0.1				2,180,253			$	0.1				4.2		2,180,253	$	0.1		4.2
	$	0.2				833,333			$	0.2				7.3		833,333	$	0.2		7.3
	$	0.3				833,334			$	0.3				7.3		833,334	$	0.3		7.3
						4,846,920			$	0.15				4.4		3,846,920	$	0.16		5.5
	A summary of the non-vested shares subject to options granted under the Equity Incentive Plans as of December 31, 2014 and 2013 is as follows:
			Stock				Weighted Average Grant Date Fair Value
			Option Shares				Per Share
	Non-vested at December 31, 2012			4,006,794			$	0.05
	Granted during the period			--				--
	Vested during the period			(1,506,793	)		$	0.05
	Terminated during the period			(833,333	)		$	0.05
	Non-vested at December 31, 2013			1,666,668			$	0.05
	Granted during the period			1,000,000			$	0.09
	Vested during the period			(833,334	)		$	0.05
	Terminated during the period			(833,334	)		$	0.05
	Non-vested at December 31, 2014			1,000,000			$	0.09
	As of December 31, 2014, there was $51,762 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Equity Incentive Plans. That cost is expected to be recognized over a weighted average period of forty-four months.
	Warrants to Purchase Common Stock
	A summary of warrant transactions during the years ended December 31, 2014 and 2013 is as follows:
			Warrant Shares				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
	Outstanding at December 31, 2012			45,852,998			$	0.17			$	--
	Issued during the period			1,151,567			$	0.04
Exercised during the period			--				--
Terminated during the period			(10,160,000	)		$	0.33
Outstanding at December 31, 2013			36,844,565			$	0.12			$	95,584
Issued during the period			620,000			$	0.06
Exercised during the period			--				--
Terminated during the period			(8,555,687	)		$	0.16
Outstanding at December 31, 2014			28,908,878			$	0.12			$	42,006
Exercisable at December 31, 2014			28,908,878			$	0.12			$	42,006
Exercisable at December 31, 2013			36,844,565			$	0.12			$	95,584
Warrants issued by the Company contain exercise prices as determined by the Company’s board of directors, but such exercise prices were generally not less than the fair market value of the Company's common stock on the date of issuance. Warrants issued may vest over a period of up to three years and have a maximum term of ten years from the date of issuance.
The fair value of the warrants issued during the years ended December 31, 2014 and 2013 was $15,318 and $36,600, respectively, and was calculated using the Black-Scholes pricing model with the following weighted average assumptions:
		Year Ended
		December 31,				December 31,
		2014				2013
Exercise price			$0.06 - $0.08				$0.035 - $0.04
Issue date stock price			$0.055 - $0.07				$0.035 - $0.095
Expected volatility			134% - 140%				123% - 141%
Risk-free interest rates			0.47% - 0.49%				0.35% - 1.36%
Risk of forfeiture			35	%			35	%
Expected life (in years)			2.0 - 2.4				3.0 - 5.0
Dividend yield			0	%			0	%
The risk-free interest rate is based on a treasury instrument, the term of which is consistent with the expected life of the warrants. In projecting expected stock price volatility, the Company used historical stock price volatility of its common stock which the Company believes is representative of future volatility. The Company estimated the expected life of warrants based on historical experience using warrant exercise and warrant expiration data.
Information with respect to outstanding warrants and warrants exercisable at December 31, 2014 is as follows:
				Warrants Outstanding										Warrants Exercisable
Range of				Number of Shares Available Under Outstanding Warrants				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price Per Common Share		Number of Shares Available for Purchase Under Outstanding Warrants		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
Exercise Prices
$	0.03 - 0.04				1,151,567				2			$	0.04		1,151,567	$	0.04		2
$	0.06 - 0.10				20,176,061				3.5			$	0.09		20,176,061	$	0.09		3.5
$	0.2				7,581,250				0.5			$	0.2		7,581,250	$	0.2		0.5
					28,908,878				2.7			$	0.12		28,908,878	$	0.12		2.7
As of December 31, 2014 and 2013, there were no non-vested shares subject to warrants and no unrecognized compensation cost related to warrants.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related-Party Transactions [Abstract]
Related Party Transactions	13	Related-Party Transactions
	Except as disclosed below, there has not been any transaction or series of related transactions to which the Company was a participant during the years ended December 31, 2014 and 2013 involving an amount in excess of $120,000 and in which a related party to the Company had or will have a direct or indirect material interest.
	During the year ended December 31, 2013, the Company sold to E. Wayne Kinsey III, a member of the Company’s board of directors, in a private placement, 8,333,334 shares of the Company’s common stock for an aggregate purchase price of $250,000, or $0.03 per share. The $0.03 per share price was the same price offered to other non-affiliated investors in the private placement of the Company’s common stock. See Note 13 – Stockholders’ Equity (Deficiency): Common Stock.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Commitments and Contingencies	14	Commitments and Contingencies
	Operating Leases
	The Company conducts its operations in leased facilities under operating lease agreements that expire through fiscal 2018. Each of the Company’s lease agreements require the Company to maintain the facilities during the term of the lease and to pay all utilities and other costs associated with those facilities, with certain exceptions. In each of the Company’s lease agreements the Company is not responsible for the payment of property taxes or property insurance, but is required to insure the contents of each facility. These lease agreements contain customary representations and warranties of the Company and subject the Company to certain financial covenants and indemnities. In the event the Company defaults on a lease, typically the landlord may terminate the lease, accelerate payments and collect liquidated damages. As of December 31, 2014, the Company was not in default of any covenants contained in its lease agreements. Certain of the Company’s lease agreements provide for renewal options. Such renewal options are at rates similar to the current rates under the lease agreements.
	Future minimum lease payments under all of the Company’s operating leases at December 31, 2014 are as follows:
	Year Ending		Amount
	December 31,
	2015		$	134,050
	2016			137,400
	2017 and thereafter			117,350
			$	388,800
	Rent expense for these locations for the years ended December 31, 2014 and 2013 was $59,046 and $71,291, respectively.
	Litigation with Crystal Enterprises
	On January 12, 2012, a civil complaint was filed against the Company in the United States District Court for the Western District of Washington by Crystal Enterprises, Inc. In its complaint, Crystal alleged interference with prospective advantage or business expectancy, tortious interference with contract, breach of fiduciary duty, breach of non-disclosure agreement and breach of contact. Crystal’s allegations centered on discussions among the Company, Crystal, Pendred, Inc. (an affiliate of Crystal) and Biolize Products, LLC, regarding the establishment of a business relationship involving the distribution of Anolyte and Catholyte. Crystal sought monetary damages as well as attorney fees. The Company refuted all claims made by Crystal, including the monetary damages claimed by Crystal.
	On June 26, 2013, the Company entered into a Confidential Settlement Agreement (the “Settlement Agreement”) with Crystal and Pendred, Inc. related to the civil complaint in order to resolve the dispute and to avoid further litigation costs associated with defending the litigation. Pursuant to the Settlement Agreement, neither party admitted to any wrongdoing, the parties agreed to unconditional mutual releases regarding, among other things, all of the claims made by Crystal in the civil complaint and the Company issued 450,000 shares of common stock to Crystal (see Note 12). The total expense associated with the issuance of these shares was $26,550, representing the fair market value of the shares of common stock on the date of issuance to Crystal ($0.059 per share).
	Litigation with Former Executive Vice President - Operations
	On June 17, 2014, a civil complaint was filed against the Company and one of its directors, E. Wayne Kinsey, III, in the Court of Common Pleas, County of Horry, State of South Carolina, by Marion Sofield, the Company’s former Executive Vice President - Operations. In her complaint, Ms. Sofield alleges breach of contract and fraud/fraudulent inducement by the Company against her with regard to her employment agreement and the termination of her employment. Ms. Sofield also alleges the Company and Mr. Kinsey engaged in a civil conspiracy and unfair trade practices and that Mr. Kinsey engaged in tortious interference. Ms. Sofield claims that she is owed additional compensation under her terminated employment agreement, and is seeking the recovery of such compensation as well as attorney’s fees and punitive damages.
	On July 18, 2014, the Company filed a motion to dismiss this state court action due to the binding arbitration clause contained in Ms. Sofield’s employment agreement that applies to a majority of the allegations in the complaint. On December 8, 2014, the court entered a consent order that: (a) granted the Company’s request to compel binding arbitration of the breach of contract and fraud claims; and (b) stayed the remaining causes of action in the South Carolina state court until the aforementioned binding arbitration process is complete.
	The Company does not believe there is any merit to Ms. Sofield’s allegations and will continue to vigorously defend this action.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	15	Subsequent Events
	Sale of Common Stock and Common Stock Units
	On February 9, 2015, the Company sold (a) an aggregate of 36,500,000 shares of the Company’s common stock for an aggregate purchase price of $1,460,000, or $0.04 per share, and (b) common stock units that in aggregate consisted of 7,575,758 shares of its common stock and warrants to purchase 3,787,880 shares of its common stock for an aggregate purchase price of $500,000, or $0.066 per share. The Company paid an aggregate of $68,300 of offering costs in cash and issued 1,055,303 shares of common stock to non-affiliated third parties as payment of $56,000 of offering costs related to these sales of common stock and common stock units.
	The warrants have a three-year term, are exercisable at $0.066 per share and were fully vested at the date of issuance. In addition, the warrants are callable by the Company in the event that the closing price of its common stock for at least fifteen trading days in any consecutive twenty trading day period is equal to or greater than $0.132, provided that at least six months has lapsed from the issuance date of the warrants.
	Issuance of Common Stock to Executive Officers
	On March 25, 2015, the Company issued an aggregate of 5,683,000 shares of common stock as stock-based compensation to its executive officers as follows: David R. LaVance, President and Chief Executive Officer – 3,613,250 shares; and Thomas S. Gifford, Executive Vice President and Chief Financial Officer – 2,069,750 shares.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Summary Of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company based its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate. All of these estimates reflect management's best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions persist longer or deteriorate further than expected, it is reasonably possible that the judgments and estimates could change.
Concentration of Credit Risk	Concentration of Credit Risk
	The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts which, at times, exceed federally-insured limits.
	The Company principally sells its products directly to commercial customers in the oil and gas industry and in several other industries. The Company’s oil and gas customers are located in Utah and in New Mexico and the Company’s other customers are located in diversified geographical regions throughout the United States. During the year ended December 31, 2014, four customers accounted for 29%, 15%, 13% and 10%, respectively, of revenues. During the year ended December 31, 2013, four customers accounted for 22%, 14%, 14% and 11%, respectively, of revenues. No other customer accounted for more than 10% of our revenues during the year ended December 31, 2014 or 2013. The Company regularly evaluates the creditworthiness of its customers.
Accounts Receivable	Accounts Receivable
	Accounts receivable consist of trade receivables recorded at original invoice amount, less any allowance for uncollectible accounts. Trade credit is generally extended on a short-term basis; thus trade receivables do not bear interest. Trade receivables are periodically evaluated for collectability by considering a number of factors, including the length of time an invoice is past due, the customer’s creditworthiness and historical bad debt experience. Changes in the estimated collectability of trade receivables are recorded in the results of operations for the period in which the estimate is revised. Trade receivables that are deemed uncollectible are offset against the allowance for uncollectible accounts. The Company generally does not require collateral for trade receivables.
Inventory	Inventory
	Inventory is recorded at the lower of cost or market using the first-in, first-out method. The Company determines its reserve for obsolete inventory by considering a number of factors, including product shelf life, marketability, and obsolescence. The Company determines the need to write down inventories by analyzing product expiration, market conditions, and salability of its products.
Property and Equipment	Property and Equipment
	Property and equipment are recorded at cost less allowances for depreciation. The straight-line method of depreciation is used for all property and equipment. Repair and maintenance costs are expensed as incurred. Equipment is depreciated over an estimated useful life ranging from three to seven years.  Leasehold improvements are depreciated over the shorter of the original term of lease or the estimated useful life of the improvement.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The carrying amounts of the Company’s financial instruments, which include cash, accounts receivable, other receivables, accounts payable and accrued expenses, approximate their fair values due to their short maturities.
	The fair value of notes payable, convertible debentures and convertible promissory notes approximate fair value since each of these investments are at market rates currently available to the Company.
Long-Lived Assets	Long-Lived Assets
	The Company reviews its long-lived assets, which include property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with Accounting Standards Codification (“ASC”) 360-10-35-15, “Property, Plant and Equipment-Impairment or Disposal of Long-Lived Assets.” Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by the assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. There were no material impairment charges related to the Company’s property and equipment during the year ended December 31, 2014 or 2013.
Revenue Recognition	Revenue Recognition
	General
	Revenue is recognized when persuasive evidence of an arrangement exists, title and risk of ownership have passed, the sales price is fixed or determinable and collectability is probable. Generally, these criteria are met at the time the product is shipped. Provisions for estimated returns, rebates and discounts are provided for at the time the related revenue is recognized. Freight revenue billed to customers is included in sales and the related shipping expense is included in cost of sales. Service revenue is recognized in the period the service is performed or ratably over the period of the related service contract.
	Leases
	When the Company leases its equipment, the accounting involves specific determinations, which often involve complex provisions and significant judgments. The four criteria of the accounting standard that the Company uses in the determination of a sales-type lease or operating-type lease are: (a) a review of the lease term to determine if it is equal to or greater than 75% of the economic life of the equipment; (b) a review of the minimum lease payments to determine if they are equal to or greater than 90% of the fair market value of the equipment; (c) a determination of whether or not the lease transfers ownership to the lessee at the end of the lease term; and (d) a determination of whether or not the lease contains a bargain purchase option. If the lease transaction meets one of the four criteria, then it is recorded as a sales-type lease; otherwise, it is recorded as an operating-type lease. Additionally, the Company assesses whether collectability of the lease payments is reasonably assured and whether there are any significant uncertainties related to costs that it has yet to incur with respect to the lease.
	When a customer enters into a sales-type lease agreement, the sales and cost of sales are recognized at the inception of the lease. The sales-type lease consists of the sum of the total minimum lease payments less unearned interest income and estimated executory cost. Minimum lease payments are part of the lease agreement between the Company (lessor) and the customer (lessee).  The discount rate implicit in the sales-type lease is used to calculate the present value of minimum lease payments, which the Company records as a lease receivable.  The minimum lease payment consists of the gross lease payments net of executory costs and contingencies, if any. Unearned interest income is amortized over the lease term to produce a constant periodic rate of return on net investment in the lease.  While revenue is recognized at the inception of the lease, the cash flow from the sales-type lease occurs over the course of the lease, which results in interest income. Sales-type lease revenue consists of the initial sale of the equipment shipped and the interest and license elements of the lease payments as they are earned.
	When a customer enters into an operating-type lease agreement, equipment lease revenue is recognized on a straight-line basis over the life of the lease, while the cost of the leased equipment is depreciated over its estimated useful life.
Income Taxes	Income Taxes
	The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires that the Company recognize a current tax liability or asset for current taxes payable or refundable and a deferred tax liability or asset for the estimated future tax effects of temporary differences and carry-forwards to the extent they are realizable. The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be realized. While the Company has considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, in the event the Company was to determine that it would be able to realize the deferred tax assets in the future in excess of the net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made. Likewise, deferred tax assets are reduced by a valuation allowance, when in the Company’s opinion, it is more likely than not that some portion or all of the deferred tax asset will not be realized.
Research and Development	Research and Development
	The Company expenses research and development costs as incurred.
Stock-based compensation	Stock-Based Compensation
	The Company accounts for stock-based payments to employees in accordance with ASC 718, “Stock Compensation” (“ASC 718”). Stock-based payments to employees include issuances of stock, grants of stock options and issuance of warrants that are recognized in the consolidated statement of operations based on their fair values at the date of grant or issuance.
	The Company accounts for stock-based payments to non-employees in accordance with ASC 718 and Topic 505-50, “Equity-Based Payments to Non-Employees.” Stock-based payments to non-employees include issuances of stock, grants of stock options and issuances of warrants that are recognized in the consolidated statement of operations based on the value of the vested portion of the award over the requisite service period as measured at its then-current fair value as of each financial reporting date.
	The Company calculates the fair value of option grants and warrant issuances utilizing the Black-Scholes pricing model. The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. ASC 718 requires forfeitures to be estimated at the time stock options are granted and warrants are issued to employees and non-employees, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered stock option or warrant. The Company estimates forfeiture rates for all unvested awards when calculating the expense for the period. In estimating the forfeiture rate, the Company monitors both stock option and warrant exercises as well as employee termination patterns.
	The resulting stock-based compensation expense for both employee and non-employee awards is generally recognized on a straight-line basis over the requisite service period of the award.
	During the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense as follows:
		Year Ended
		December 31,
		2014		2013
	General and administrative	$	61,712	$	90,969
	Sales and marketing		15,498		10,220
	Research and development		4,383		4,380
	Total	$	81,593	$	105,569
	For the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense related to stock options granted to employees and directors of $37,724 and $48,607, respectively. For the years ended December 31, 2014 and 2013, the Company recorded stock-based compensation expense related to common stock and warrants issued to non-employees of $43,869 and $56,962, respectively.
Net Loss Per Common Share	Net Loss Per Common Share
	Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect, in periods in which they have a dilutive effect, the impact of common shares issuable upon exercise of stock options and warrants and conversion of convertible debt that are not deemed to be anti-dilutive. The dilutive effect of the outstanding stock options and warrants is computed using the treasury stock method.
	For the year ended December 31, 2014, diluted net loss per share did not include the effect of 4,846,920 shares of common stock issuable upon the exercise of outstanding stock options, 28,908,878 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debentures, as their effect would be anti-dilutive.
	For the year ended December 31, 2013, diluted net loss per share did not include the effect of 4,980,254 shares of common stock issuable upon the exercise of outstanding stock options, 36,844,565 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debentures, as their effect would be anti-dilutive.
Reclassifications	Reclassifications
	Certain reclassifications have been made to prior periods to conform to current presentations.
Recent Accounting Pronouncements Applicable to the Company	Recent Accounting Pronouncements Applicable to the Company
	The Company does not believe there are any recently issued, but not yet effective, accounting standards that would have a significant impact on the Company’s financial position or results of operations.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Summary Of Significant Accounting Policies [Abstract]
Schedule of recognized stock-based compensation expense		Year Ended
		December 31,
		2014		2013
	General and administrative	$	61,712	$	90,969
	Sales and marketing		15,498		10,220
	Research and development		4,383		4,380
	Total	$	81,593	$	105,569

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property and Equipment [Abstract]
Components of property and equipment, on a net basis		Year Ended
		December 31,
		2014			2013
	Leasehold improvements	$	328,977		$	328,977
	Equipment		437,504			437,504
			766,481			766,481
	Less:  Accumulated depreciation		(507,013	)		(421,597	)
		$	259,468		$	344,884

Accrued_Expenses_Tables

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Accrued Expenses [Abstract]
Components of accrued expenses		Year Ended
		December 31,
		2014		2013
	Accrued compensation	$	253,305	$	--
	Accrued penalty (see Note 5)		87,344		--
	Accrued interest (see Note 9)		27,321		24,321
	Accrued professional fees		22,000		22,000
	Accrued other expenses		13,550		1,633
		$	403,520	$	47,954

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Summary of difference between statutory federal income tax rate and effective income tax rate		Years Ended
		December 31,						December 31,
		2014						2013
		Amount			Percent			Amount			Percent
	Income tax provision at federal statutory rate	$	(759,617	)		34	%	$	(622,626	)		34	%
	Effect of state taxes, net of federal benefit		(67,025	)		3			(54,938	)		3
	Change in valuation allowance		793,408			(36	)		679,700			(37	)
	Other		(33,234	)		(1	)		(2,136	)		--
		$	--			--	%	$	--			--	%
Summary of tax effects of temporary differences and net operating loss carryforwards rise to deferred taxes		Years Ended
		December 31,
		2014			2013
	Net operating loss	$	7,471,805		$	6,710,397
	Depreciation and amortization		65,820			53,604
	Stock based compensation		328,993			309,208
	Total gross deferred tax assets		7,866,618			7,073,209
	Valuation allowance		(7,866,618	)		(7,073,209	)
	Net deferred tax assets	$	--		$	--

Stockholders_Equity_Deficiency1

Stockholders' Equity (Deficiency) (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock option and warrants transactions under equity incentive plan			Stock				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
			Option Shares
	Outstanding at December 31, 2012			5,813,587			$	0.18			$	--
	Granted during the period			--				--
	Exercised during the period			--				--
	Terminated during the period			(833,333	)		$	0.2
	Outstanding at December 31, 2013			4,980,254			$	0.18			$	55,605
	Granted during the period			1,000,000				0.09
	Exercised during the period			--				--
	Terminated during the period			(1,133,334	)		$	0.24
	Outstanding at December 31, 2014			4,846,920			$	0.15			$	--
	Exercisable at December 31, 2014			3,846,920			$	0.16			$	--
	Exercisable at December 31, 2013			3,313,586			$	0.12			$	42,136
Schedule of share-based compensation, outstanding options and options exercisable					Stock Options Outstanding										Stock Options Exercisable
	Exercise				Number of Shares Available Under Outstanding Stock				Weighted Average Exercise Price Per Common Share				Weighted Average Remaining Contractual Life (Years)		Number of Shares Available for Purchase Under Outstanding Stock		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
	Price				Options										Options
	$	0.09				1,000,000			$	0.09				9.7		--	$	0.09		--
	$	0.1				2,180,253			$	0.1				4.2		2,180,253	$	0.1		4.2
	$	0.2				833,333			$	0.2				7.3		833,333	$	0.2		7.3
	$	0.3				833,334			$	0.3				7.3		833,334	$	0.3		7.3
						4,846,920			$	0.15				4.4		3,846,920	$	0.16		5.5
Schedule of nonvested share activity			Stock				Weighted Average Grant Date Fair Value
			Option Shares				Per Share
	Non-vested at December 31, 2012			4,006,794			$	0.05
	Granted during the period			--				--
	Vested during the period			(1,506,793	)		$	0.05
	Terminated during the period			(833,333	)		$	0.05
	Non-vested at December 31, 2013			1,666,668			$	0.05
	Granted during the period			1,000,000			$	0.09
	Vested during the period			(833,334	)		$	0.05
	Terminated during the period			(833,334	)		$	0.05
	Non-vested at December 31, 2014			1,000,000			$	0.09
Schedule of fair value of stock option and warrants issued using Black-Scholes pricing model	Exercise price		$	0.09
	Grant date stock price		$	0.09
	Expected volatility			139	%
	Risk-free interest rates			2.39	%
	Risk of forfeiture			35	%
	Expected life (in years)			10
	Dividend yield			0	%
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock option and warrants transactions under equity incentive plan			Warrant Shares				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
	Outstanding at December 31, 2012			45,852,998			$	0.17			$	--
	Issued during the period			1,151,567			$	0.04
	Exercised during the period			--				--
	Terminated during the period			(10,160,000	)		$	0.33
	Outstanding at December 31, 2013			36,844,565			$	0.12			$	95,584
	Issued during the period			620,000			$	0.06
	Exercised during the period			--				--
	Terminated during the period			(8,555,687	)		$	0.16
	Outstanding at December 31, 2014			28,908,878			$	0.12			$	42,006
	Exercisable at December 31, 2014			28,908,878			$	0.12			$	42,006
	Exercisable at December 31, 2013			36,844,565			$	0.12			$	95,584
Schedule of share-based compensation, outstanding options and options exercisable					Warrants Outstanding										Warrants Exercisable
	Range of				Number of Shares Available Under Outstanding Warrants				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price Per Common Share		Number of Shares Available for Purchase Under Outstanding Warrants		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
	Exercise Prices
	$	0.03 - 0.04				1,151,567				2			$	0.04		1,151,567	$	0.04		2
	$	0.06 - 0.10				20,176,061				3.5			$	0.09		20,176,061	$	0.09		3.5
	$	0.2				7,581,250				0.5			$	0.2		7,581,250	$	0.2		0.5
						28,908,878				2.7			$	0.12		28,908,878	$	0.12		2.7
Schedule of fair value of stock option and warrants issued using Black-Scholes pricing model			Year Ended
			December 31,				December 31,
			2014				2013
	Exercise price			$0.06 - $0.08				$0.035 - $0.04
	Issue date stock price			$0.055 - $0.07				$0.035 - $0.095
	Expected volatility			134% - 140%				123% - 141%
	Risk-free interest rates			0.47% - 0.49%				0.35% - 1.36%
	Risk of forfeiture			35	%			35	%
	Expected life (in years)			2.0 - 2.4				3.0 - 5.0
	Dividend yield			0	%			0	%

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Summary of future minimum lease payments under operating leases	Year Ending	Amount
	December 31,
	2015	$	134,050
	2016		137,400
	2017 and thereafter		117,350
		$	388,800

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Basis of Presentation (Textual)
Accumulated deficit	($21,714,820)	($19,480,652)
Working capital deficiency	$458,298

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule of recognized stock-based compensation expense
Stock-based compensation expense	$81,593	$105,569
General and administrative [Member]
Schedule of recognized stock-based compensation expense
Stock-based compensation expense	61,712	90,969
Sales and marketing [Member]
Schedule of recognized stock-based compensation expense
Stock-based compensation expense	15,498	10,220
Research and development [Member]
Schedule of recognized stock-based compensation expense
Stock-based compensation expense	$4,383	$4,380

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	Customers	Customers
Summary of Significant Accounting Policies (Textual)
Recorded stock-based compensation expense related to stock options and warrants	$81,593	$105,569
Customers accounted for total revenue	No other customer accounted for more than 10% of our revenues	No other customer accounted for more than 10% of our revenues
Criteria for determination of lease type	(a) a review of the lease term to determine if it is equal to or greater than 75% of the economic life of the equipment; (b) a review of the minimum lease payments to determine if they are equal to or greater than 90% of the fair market value of the equipment; (c) a determination of whether or not the lease transfers ownership to the lessee at the end of the lease term; and (d) a determination of whether or not the lease contains a bargain purchase option. If the lease transaction meets one of the four criteria, then it is recorded as a sales-type lease; otherwise, it is recorded as an operating-type lease.
Number of customers	4	4
Employees [Member]
Summary of Significant Accounting Policies (Textual)
Recorded stock-based compensation expense related to stock options and warrants	37,724	48,607
Nonemployees [Member]
Summary of Significant Accounting Policies (Textual)
Recorded stock-based compensation expense related to stock options and warrants	$43,869	$56,962
Stock Options [Member]
Summary of Significant Accounting Policies (Textual)
Anti-dilutive securities	4,846,920	4,980,254
Warrant [Member]
Summary of Significant Accounting Policies (Textual)
Anti-dilutive securities	28,908,878	36,844,565
Convertible Debt Securities [Member]
Summary of Significant Accounting Policies (Textual)
Anti-dilutive securities	4,823,750	4,823,750
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment estimated useful life	7 years
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment estimated useful life	3 years
Sales revenue, segment [Member] | Customer one [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk, percentage	29.00%	22.00%
Sales revenue, segment [Member] | Customer two [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk, percentage	15.00%	14.00%
Sales revenue, segment [Member] | Customer three [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk, percentage	13.00%	14.00%
Sales revenue, segment [Member] | Customer four [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk, percentage	10.00%	11.00%

Inventory_Details

Inventory (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
Inventory (Textual)
Inventory parts and materials	$117,690	$126,952
Reclassification of equipment from finished goods inventory to fixed assets			$17,487

Other_Receivable_Details

Other Receivable (Details) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Mar. 05, 2015	Feb. 28, 2015
Other Receivable (Textual)
Penalty	$87,344
Other receivable	111,200
Legal expenses	23,856
Accrued liability	87,344
Subsequent Event [Member]
Other Receivable (Textual)
Penalty			87,344
Legal expenses		37,500
Receivable from licensee		$124,844

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Components of property and equipment, on a net basis
Leasehold improvements	$328,977	$328,977
Equipment	437,504	437,504
Property and equipment, Gross	766,481	766,481
Less: Accumulated depreciation	-507,013	-421,597
Property and equipment, net	$259,468	$344,884

Accrued_Expenses_Details

Accrued Expenses (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Components of accrued expenses
Accrued compensation	$253,305
Accrued penalty (see Note 5)	87,344
Accrued interest (see Note 9)	27,321	24,321
Accrued professional fees	22,000	22,000
Accrued other expenses	13,550	1,633
Accrued liabilities, total	$403,520	$47,954

Customer_Deposits_Details

Customer Deposits (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Customer Deposits (Textual)
Customer deposits	$2,000	$38,109
Gain on settlement of customer deposit	36,109
Consulting services	$36,109

Convertible_Debentures_Details

Convertible Debentures (Details) (USD $)	0 Months Ended	1 Months Ended	12 Months Ended		0 Months Ended		1 Months Ended
	Aug. 21, 2012	Aug. 17, 2012	Dec. 31, 2014	Dec. 31, 2013	Apr. 26, 2007	Oct. 10, 2014	Aug. 22, 2013	Sep. 23, 2011	Jul. 07, 2011
Convertible Debentures (Textual)
Convertible debenture issued, Principal amount								$100,000
Convertible debenture, Interest Rate								8.00%
Convertible debenture,Interest expense			48,323	45,913
Common stock issued pursuant to the Secured Notes	122,017	4,000,000
Outstanding principal				476,125
Convertible debenture, Conversion Price		$0.10
April 2007 Convertible Debenture [Member]
Convertible Debentures (Textual)
Convertible debenture issued, Principal amount					25,000
Convertible debenture, Maturity Date					2-Jan-09
Convertible debenture, Interest Rate					12.00%
Convertible debenture,Interest expense			3,000	2,992
Outstanding principal			25,000	25,000
Accrued and unpaid interest on convertible debt			13,441	10,441
Convertible debenture, Conversion Price					$0.40
Common stock issued as payment on principal and interest on convertible debentures, shares					62,500
Zanett Convertible Debenture [Member]
Convertible Debentures (Textual)
Convertible debenture issued, Principal amount	476,125							100,000	376,125
Convertible debenture, Maturity Date	21-Aug-15
Convertible debenture, Interest Rate	8.00%							8.00%	8.00%
Convertible debenture,Interest expense			38,090	38,090
Common stock issued pursuant to the Secured Notes	4,761,250						400,947
Outstanding principal			476,125	476,125
Accrued and unpaid interest on convertible debt			$13,880	$13,880		$38,090	$38,090
Convertible debenture, Conversion Price	0.1
Condition for conversion of debt amount to common stock			The occurrence of the merger or acquisition of the Company or if the average closing price of the Company's common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share.
Common stock issued as payment on principal and interest on convertible debentures, shares						437,816
Common stock quoted market price	0.05					$0.09	$0.10

Note_Payable_Details

Note Payable (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Sep. 23, 2011
	Machine
Note Payable (Textual)
Convertible promissory notes, interest percentage			8.00%
Notes payable current portion	$46,546	$75,513
Note payable long term portion		46,546
Asset Purchase Agreement [Member]
Note Payable (Textual)
Convertible promissory notes, interest percentage	7.00%
Convertible promissory notes, maturity date	1-Aug-13
Periodic payment	6,805
Description of payment term	Twenty-four monthly payments.
Interest expense	6,152	4,086
Notes Payable		122,059
Notes payable current portion	46,546	75,513
Note payable long term portion		46,546
Number of machines purchase agreement	19
Purchase price of asset	190,000
Payment in closing of asset purchase agreement	38,000
Issuance of promissory note principal balance	$152,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary of difference between statutory federal income tax rate and effective income tax rate
Income tax provision at federal statutory rate, Amount	($759,617)	($622,626)
Income tax provision at federal statutory rate, Percent	34.00%	34.00%
Effect of state taxes, net of federal benefit, Amount	-67,025	-54,938
Effect of state taxes, net of federal benefit, Percent	3.00%	3.00%
Change in valuation allowance, Amount	793,408	679,700
Change in valuation allowance, Percent	-36.00%	-37.00%
Other, Amount	-33,234	-2,136
Other, Percent	-1.00%
Total, Amount
Total, Percent

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of tax effects of temporary differences and net operating loss carryforwards rise to deferred taxes
Net operating loss	$7,471,805	$6,710,397
Depreciation and amortization	65,820	53,604
Stock based compensation	328,993	309,208
Total gross deferred tax assets	7,866,618	7,073,209
Valuation allowance	-7,866,618	-7,073,209
Net deferred tax assets

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014
Income Taxes (Textual)
Valuation allowance attributable to continuing operating losses	$793,408
Federal and state operating losses	$19,989,000
Expiration duration of federal and state operating losses	Begin to expire in the years 2021 through 2034.

Stockholders_Equity_Deficiency2

Stockholders' Equity (Deficiency) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options [Member]
Summary of stock option and warrant transactions
Outstanding, Number, Beginning Balance	4,980,254
Granted during the period, Shares	1,000,000
Exercised during the period, Shares
Terminated during the period, Shares	-1,133,334	-833,333
Outstanding shares, Ending balance	4,846,920	4,980,254
Exercisable, Ending balance	3,846,920	3,313,586
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.18
Grants in Period, Weighted Average Exercise Price	$0.09
Exercises in Period, Weighted Average Exercise Price
Terminated, Weighted Average Exercise Price	$0.24	$0.20
Outstanding, Weighted Average Exercise Price, Ending balance	$0.15	$0.18
Exercisable, Weighted Average Exercise Price	$0.16	$0.12
Outstanding, Aggregate Intrinsic Value, Beginning balance	$55,605
Outstanding, Aggregate Intrinsic Value, Ending balance		55,605
Exercisable, Intrinsic Value		42,136
Warrant [Member]
Summary of stock option and warrant transactions
Outstanding, Number, Beginning Balance	36,844,565
Granted during the period, Shares	620,000	1,151,567
Exercised during the period, Shares
Terminated during the period, Shares	-8,555,687	-10,160,000
Outstanding shares, Ending balance	28,908,878	36,844,565
Exercisable, Ending balance	28,908,878	36,844,565
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.12
Grants in Period, Weighted Average Exercise Price	$0.06	$0.04
Exercises in Period, Weighted Average Exercise Price
Terminated, Weighted Average Exercise Price	$0.16	$0.33
Outstanding, Weighted Average Exercise Price, Ending balance	$0.12	$0.12
Exercisable, Weighted Average Exercise Price	$0.12	$0.12
Outstanding, Aggregate Intrinsic Value, Beginning balance	95,584
Outstanding, Aggregate Intrinsic Value, Ending balance	42,006	95,584
Exercisable, Intrinsic Value	$42,006	$95,584

Stockholders_Equity_Deficiency3

Stockholders' Equity (Deficiency) (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Exercise price	0.09
Grant date stock price	0.09
Expected volatility	139.00%
Risk-free interest rates	2.39%
Risk of forfeiture	35.00%
Expected life (in years)	10 years
Dividend yield	0.00%
Warrant [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Risk of forfeiture	35.00%	35.00%
Dividend yield	0.00%	0.00%
Warrant [Member] | Minimum [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Exercise price	0.06	0.035
Grant date stock price	0.055	0.035
Expected volatility	134.00%	123.00%
Risk-free interest rates	0.47%	0.35%
Expected life (in years)	2 years	3 years
Warrant [Member] | Maximum [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Exercise price	0.08	0.04
Grant date stock price	0.07	0.095
Expected volatility	140.00%	141.00%
Risk-free interest rates	0.49%	1.36%
Expected life (in years)	2 years 4 months 24 days	5 years

Stockholders_Equity_Deficiency4

Stockholders' Equity (Deficiency) (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Summary of stock option and warrant transactions
Number of Shares Available Under Outstanding Stock Options/ Warrants	4,846,920	4,980,254
Weighted Average Exercise Price Per Common Share	$0.15	$0.18
Weighted Average Remaining Contractual Life (Years)	4 years 4 months 24 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	3,846,920	3,313,586
Weighted Average Exercise Price Per Common Share	$0.16	$0.12
Weighted Average Remaining Contractual Life (Years)	5 years 6 months
Employee Stock Option [Member] | Range 1 [Member]
Summary of stock option and warrant transactions
Range of exercise prices	$0.09
Number of Shares Available Under Outstanding Stock Options/ Warrants	1,000,000
Weighted Average Exercise Price Per Common Share	$0.09
Weighted Average Remaining Contractual Life (Years)	9 years 8 months 12 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants
Weighted Average Exercise Price Per Common Share	$0.09
Employee Stock Option [Member] | Range 2 [Member]
Summary of stock option and warrant transactions
Range of exercise prices	$0.10
Number of Shares Available Under Outstanding Stock Options/ Warrants	2,180,253
Weighted Average Exercise Price Per Common Share	$0.10
Weighted Average Remaining Contractual Life (Years)	4 years 2 months 12 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	2,180,253
Weighted Average Exercise Price Per Common Share	$0.10
Weighted Average Remaining Contractual Life (Years)	4 years 2 months 12 days
Employee Stock Option [Member] | Range 3 [Member]
Summary of stock option and warrant transactions
Range of exercise prices	$0.20
Number of Shares Available Under Outstanding Stock Options/ Warrants	833,333	833,333
Weighted Average Exercise Price Per Common Share	$0.20
Weighted Average Remaining Contractual Life (Years)	7 years 3 months 18 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	833,333	833,333
Weighted Average Exercise Price Per Common Share	$0.20	$0.20
Weighted Average Remaining Contractual Life (Years)	7 years 3 months 18 days
Employee Stock Option [Member] | Range 4 [Member]
Summary of stock option and warrant transactions
Range of exercise prices	$0.30
Number of Shares Available Under Outstanding Stock Options/ Warrants	833,333	1,666,668
Weighted Average Exercise Price Per Common Share	$0.30
Weighted Average Remaining Contractual Life (Years)	7 years 3 months 18 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	833,333
Weighted Average Exercise Price Per Common Share	$0.30
Weighted Average Remaining Contractual Life (Years)	7 years 3 months 18 days
Warrant [Member]
Summary of stock option and warrant transactions
Number of Shares Available Under Outstanding Stock Options/ Warrants	28,908,878	36,844,565
Weighted Average Exercise Price Per Common Share	$0.12	$0.12
Weighted Average Remaining Contractual Life (Years)	2 years 8 months 12 days
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	28,908,878	36,844,565
Weighted Average Exercise Price Per Common Share	$0.12	$0.12
Weighted Average Remaining Contractual Life (Years)	2 years 8 months 12 days
Warrant [Member] | Range 1 [Member]
Summary of stock option and warrant transactions
Range of Exercise Prices, Lower Limit	$0.03
Range of Exercise Prices, Upper Limit	$0.04
Number of Shares Available Under Outstanding Stock Options/ Warrants	1,151,567
Weighted Average Exercise Price Per Common Share	$0.04
Weighted Average Remaining Contractual Life (Years)	2 years
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	1,151,567
Weighted Average Exercise Price Per Common Share	$0.04
Weighted Average Remaining Contractual Life (Years)	2 years
Warrant [Member] | Range 2 [Member]
Summary of stock option and warrant transactions
Range of Exercise Prices, Lower Limit	$0.06
Range of Exercise Prices, Upper Limit	$0.10
Number of Shares Available Under Outstanding Stock Options/ Warrants	20,176,061
Weighted Average Exercise Price Per Common Share	$0.09
Weighted Average Remaining Contractual Life (Years)	3 years 6 months
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	20,176,061
Weighted Average Exercise Price Per Common Share	$0.09
Weighted Average Remaining Contractual Life (Years)	3 years 6 months
Warrant [Member] | Range 3 [Member]
Summary of stock option and warrant transactions
Range of exercise prices	$0.20
Number of Shares Available Under Outstanding Stock Options/ Warrants	7,581,250	12,636,937
Weighted Average Exercise Price Per Common Share	$0.20
Weighted Average Remaining Contractual Life (Years)	6 months
Number of Shares Available for Purchase Under Outstanding Stock Options/Warrants	7,581,250	12,636,937
Weighted Average Exercise Price Per Common Share	$0.20	$0.20
Weighted Average Remaining Contractual Life (Years)	6 months

Stockholders_Equity_Deficiency5

Stockholders' Equity (Deficiency) (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options [Member]
Summary of the non-vested shares subject to options granted/Warrant
Nonvested, Number, Beginning Balance	1,666,668	4,006,794
Granted during the period	1,000,000
Vested during the period	-833,334	-1,506,793
Terminated during the period	-833,334	-833,333
Non-vested Balance	1,000,000	1,666,668
Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance	$0.05	$0.05
Weighted Average Grant Date Fair Value Per Share, Granted	$0.09
Weighted Average Grant Date Fair Value Per Share, Vested	$0.05	$0.05
Weighted Average Grant Date Fair Value Per Share, Terminated	$0.05	$0.05
Weighted Average Grant Date Fair Value Per Share, Ending Balance	$0.09	$0.05
Warrant [Member]
Summary of the non-vested shares subject to options granted/Warrant
Non-vested Balance
Weighted Average Grant Date Fair Value Per Share, Ending Balance

Stockholders_Equity_Deficiency6

Stockholders' Equity (Deficiency) (Details Textual) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 09, 2015	Feb. 25, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock unit sold	20,973,693	74,388,766
Aggregate purchase price of common stock	$1,093,690	$2,827,700
Aggregate purchase price of common stock, per share	$0.05	$0.04
Offering cost	47,694	64,095
Fair value adjustment of warrants	15,318	36,600
Employee service share-based compensation	51,762
Subsequent Event [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued to directors			1,055,303
Common stock price per share			$0.04
Number of common stock under equity incentive plan				37,950,000
Non-Affiliated Third Parties [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Aggregate purchase price of common stock, per share		$0.04
Company's common stock issued for services, shares		1,000,000
Offering cost	44,252
Common stock issued	250,000
Total expense associated with issuance of shares	20,000	43,550
Common stock price per share	$0.08
Offering price share	758,711
Company's common stock issued for services	20,875
E. Wayne Kinsey, III [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Aggregate purchase price of common stock	32,250	70,250
Aggregate purchase price of common stock, per share	$0.07	$0.03
Offering cost		109,100
Common stock issued	786,628	1,713,839
Sale of stock, number of shares issued in transaction		8,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased		$0.04
Sale of stock, consideration received per transaction		$250,000
Common stock price per share		$0.03
Offering price share		1,649,874
2010 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued	90,500
Common stock reserved	10,000,000
Outstanding shares under stock option plan	3,846,920	4,980,254
2012 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock reserved	14,000,000
Outstanding shares under stock option plan	1,000,000
Number of common stock under equity incentive plan	13,000,000

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Related Party Transactions (Textual)
Related party transaction amount in excess	$120,000	$120,000
E. Wayne Kinsey, III [Member]
Related Party Transactions (Textual)
Common stock purchase price, value		$250,000
Common stock purchase price, shares		8,333,334
Price per share		$0.03

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
Future minimum lease payments
2015	$134,050
2016	137,400
2017 and thereafter	117,350
Future minimum lease payments	$388,800

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	0 Months Ended	12 Months Ended
	Mar. 14, 2013	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies (Textual)
Rental lease expense, per year		$59,046	$71,291
Common stock issuance expences	20,000
Common stock, par value		$0.00	$0.00
Operating leases agreements expiration date		31-Dec-18
Settlement Agreement [Member]
Commitments and Contingencies (Textual)
Common stock issued to Crystal			450,000
Common stock issuance expences			$26,550
Common stock, par value			$0.06

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	0 Months Ended		1 Months Ended
	Mar. 14, 2013	Feb. 09, 2015	Mar. 25, 2015
Subsequent Event Textual [Abstract]
Common stock issuance expences	$20,000
Subsequent Event [Member]
Subsequent Event Textual [Abstract]
Common stock issuance expences		56,000
Common stock issued, value		1,460,000
Common stock units, issued		36,500,000
Common stock price per share		$0.04
Common stock to non-affiliated third parties		1,055,303
Common stock to non-affiliated third parties, Value		68,300
Warrant exercise price		$0.07
Term of warrants		3 years
Description for warrant		The warrants are callable by the Company in the event that the closing price of its common stock for at least fifteen trading days in any consecutive twenty trading day period is equal to or greater than $0.132, provided that at least six months has lapsed from the issuance date of the warrants.
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event Textual [Abstract]
Common stock issued, value		$500,000
Common stock units, issued		7,575,758
Common stock price per share		$0.07
Subsequent Event [Member] | Warrant [Member]
Subsequent Event Textual [Abstract]
Common stock units, issued		3,787,880
Executive Officer [Member] | Subsequent Event [Member]
Subsequent Event Textual [Abstract]
Common stock as stock-based compensation			5,683,000
David R. LaVance [Member] | Subsequent Event [Member]
Subsequent Event Textual [Abstract]
Common stock as stock-based compensation			3,613,250
Thomas S. Gifford [Member] | Subsequent Event [Member]
Subsequent Event Textual [Abstract]
Common stock as stock-based compensation			2,069,750